Ignite Creation Date:
2025-12-24 @ 7:45 PM
Ignite Modification Date:
2026-02-23 @ 12:19 PM
Study NCT ID:
NCT03705403
Status:
TERMINATED
Last Update Posted:
2025-01-30
First Post:
2018-06-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
IMMUNOtherapy and Stereotactic ABlative Radiotherapy (IMMUNOSABR) a Phase II Study
Sponsor:
Maastricht University Medical Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-04-04
Start Date Type:
ACTUAL
Primary Completion Date:
2025-01-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-01-06
Completion Date Type:
ACTUAL
First Submit Date:
2018-06-27
First Submit QC Date:
None
Study First Post Date:
2018-10-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-01-28
Last Update Post Date:
2025-01-30
Last Update Post Date Type:
ACTUAL